Dupixent (dupilumab) is a brand-name injectable drug prescribed for asthma, eczema, and other inflammatory conditions in some adults and children. Dupixent comes in two forms: pens and syringes.

EYLEA HD achieved $6 billion in 2024 sales, with FDA decisions on extended dosing and pre-filled syringes due in 2025 ... Dupixent (dupilumab) is now used to treat over a million patients globally.

Dupixent (dupilumab) is a brand-name injection that ... Dupixent is available as a solution inside single-dose prefilled pens and syringes, given as a subcutaneous injection.

Do not use if you are allergic to dupilumab or to any of the ingredients in DUPIXENT®. Before using DUPIXENT, tell your healthcare provider about all your medical conditions, including if you ...

At the moment the biologic is delivered as a pre-filled syringe (pictured above ... such as Sanofi/Regeneron's IL-4/IL-13 inhibitor Dupixent (dupilumab) and AZ's IL-5 inhibitor Fasenra ...

Inclusion criteria: (1) Children and adolescents aged 6 months to younger than 18 years; (2) Pediatric patients treated with dupilumab injection (300 mg/2.0 ml/vial or 200 mg/1.14 ml/vial pre-filled ...

Locals near a needle exchange site in a Bronx park are cheering a councilman’s proposal to require city health workers to collect hundreds of discarded syringes littering the ground. Oswald ...

Get Instant Summarized Text (Gist) An HIV outbreak in West Virginia, primarily among people who inject drugs, persists despite federal recommendations for syringe service programs. Political ...

Friendly germs armed with their own biological syringes and poisons could hold the key to overcoming the antimicrobial resistance crisis, according to a new study by biologists at the Universities ...

Following receipt of dupilumab for 24 weeks, desensitization to peanut exposure in most children/adolescents with peanut allergy was not achieved, according to study results. Image: Adobe Stock ...

Our results support use of 30 and 60 mL syringes for the purposes of rapid pediatric fluid resuscitation when the 'disconnect-reconnect' technique is utilized. Further studies are needed to ...

Dupixent ® (dupilumab) is now used to treat over a million patients globally. The recent approval and launch in chronic obstructive pulmonary disease (COPD) has had a successful start ...